Piper Sandler Reiterates Overweight Rating on BridgeBio Pharma (BBIO)
Go back to Piper Sandler Reiterates Overweight Rating on BridgeBio Pharma (BBIO)| (NASDAQ: BBIO) | Delayed: 66.27 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.27 | 52 Week High | $ | |||
| Open | $66.27 | 52 Week Low | $ | |||
| Day High | $66.27 | P/E | N/A | |||
| Day Low | $66.27 | EPS | $ | |||
| Volume | 806 | |||||

